Dosage for PT-141 depends on the form: the FDA-approved 1.75 mg injection, nasal sprays, and research doses. Learn units, timing, frequency, and safety.
PT-141 (bremelanotide) has one FDA-approved dose: 1.75 mg injected subcutaneously, taken as needed about 45 minutes before sexual activity. It should not be repeated within 24 hours or used more than eight times per month. Because that is the only regulated dose, most of the dosage for PT-141 you see elsewhere comes from research studies, compounded products, or online forums rather than an official label.
What PT-141 Is and Why Dosing Is Confusing
Bremelanotide is a synthetic peptide that activates melanocortin receptors, mainly MC4R, in the brain. It was first studied for skin tanning before researchers noticed it increased sexual desire.
The FDA approved it in 2019 as Vyleesi for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). It is not approved for men, for erectile dysfunction, or for daily use. That narrow approval is why people asking what is pt 141 good for often get mixed answers: the drug has one legitimate indication, and everything else is off-label or experimental.
PT-141 Dosage Chart by Form
| Form | Typical dose | Timing | Status |
|---|---|---|---|
| Subcutaneous injection (Vyleesi) | 1.75 mg | At least 45 minutes before activity | FDA-approved |
| Subcutaneous injection (research) | 1.25-1.75 mg in men | 30-60 minutes before | Not approved; trial data only |
| Nasal spray | 10 mg (some trials used 20 mg) | About 45 minutes before | Not FDA-approved |
| Oral or sublingual | Not established | Variable | Not FDA-approved; poor absorption |
| Compounded or research vial | Varies by seller | Varies | Unregulated |
The injectable product is the only version with a defined dose, a defined schedule, and a defined safety profile. Nasal, oral, and compounded versions have not gone through the same review, and their absorption can differ significantly from one batch to the next.
PT-141 Dosage in Units, cc, and mcg
Units on an insulin syringe measure volume, not milligrams. On a U-100 syringe, 1 unit equals 0.01 mL, so 100 units equals 1 mL. To turn units into a dose, you need the concentration of the vial.
| Vial and diluent | Concentration | 1.75 mg equals | 1 mg equals |
|---|---|---|---|
| 10 mg powder + 1 mL water | 10 mg/mL | 0.175 mL (17.5 units) | 10 units |
| 10 mg powder + 2 mL water | 5 mg/mL | 0.35 mL (35 units) | 20 units |
| 10 mg powder + 3 mL water | 3.33 mg/mL | 0.525 mL (52.5 units) | 30 units |
This is why pt 141 dosage in cc or how many units of PT-141 should I take cannot be answered without the concentration. A 10-unit draw is 1 mg in the first vial above, 0.5 mg in the second, and 0.33 mg in the third. Getting the math wrong can easily triple or halve the intended dose.
In micrograms, the approved injection is 1,750 mcg. Compounded or research dosing that appears in forums often falls between 250 mcg and 2,000 mcg, but there is no validated dose in that range for any approved purpose.
PT-141 Dosage for Men vs Women
Vyleesi is approved only for premenopausal women. The FDA label does not provide a dose for men, so any pt 141 dosage for men is off-label, and no manufacturer has published a validated male protocol.
Clinical trials in men with erectile dysfunction tested bremelanotide injections at 1.25 mg and 1.75 mg. Results were modest, and the drug was not approved for that use. Men who use PT-141 typically follow the same 1.75 mg injection, though some online reports describe smaller amounts. Because men are not covered by the label, a clinician should be involved in any decision to use it.
Timing, Frequency, and How Often to Take It
PT-141 is an as-needed drug, not a daily one. The approved schedule is one 1.75 mg injection at least 45 minutes before anticipated sexual activity, with a maximum of one dose in 24 hours and no more than eight doses in a month.
If you are wondering pt-141 how long does it take to work, most users report effects beginning within 45 to 90 minutes, with a peak around one to two hours. Taking a second dose because the first felt weak is not recommended.
Daily use is not supported by the label. Repeated frequent dosing is linked to hyperpigmentation, a darkening of the skin, gums, and other tissue, and it also raises the risk of blood pressure changes. A PT-141 daily dosage is not part of any approved regimen.
Microdosing, Nasal Sprays, and Reddit Reports
Online communities discuss microdosing PT-141 at 0.25 mg to 0.5 mg, usually to reduce nausea. No clinical study supports microdosing, and splitting an already small dose accurately requires careful measurement.
Most discussions of pt 141 peptide spray dosage center on 10 mg delivered intranasally, which is the amount used in older nasal trials. Spray absorption is inconsistent, and a compounded spray may deliver more or less than intended. Products listed as pt-141 for sale online are not the same as the FDA-approved autoinjector, and they may contain unknown purity or concentration.
Forums are useful for spotting side-effect patterns, but they are not a dosing guide. Individual reports vary too widely to serve as a reliable PT-141 protocol.
Side Effects and Safety
- Nausea, flushing, and headache are the most common reactions.
- Injection-site reactions can occur with the subcutaneous shot.
- Blood pressure can rise briefly after a dose.
- Frequent use can cause darkening of the skin, gums, or other tissue.
- Focal hyperpigmentation may be slow to fade.
Bremelanotide is contraindicated in people with uncontrolled hypertension or known cardiovascular disease. It is not recommended during pregnancy, and it should not be combined casually with other blood-pressure-affecting drugs. Anyone considering PT-141 should review their medical history and current medications with a healthcare professional first.
Bottom Line
The only evidence-based dose is 1.75 mg subcutaneously, no more than once every 24 hours and no more than eight times a month. There is no titration step: the PT-141 starting dose and the maximum dose are the same number. Unit and cc conversions always depend on the concentration of the vial, so the same number of units can mean very different doses. Nasal, oral, and microdosed versions of PT-141 remain unproven, and unregulated products add extra risk.
Frequently Asked Questions
What is the correct dosage for PT-141?
The only FDA-approved dose is 1.75 mg injected subcutaneously, taken at least 45 minutes before anticipated sexual activity. It should not be used more than once in 24 hours or more than eight times per month. Compounded, nasal, and oral versions do not have an approved dose.
How many units of PT-141 should I take for 1.75 mg?
The number of units depends entirely on the concentration of your vial. If 10 mg of powder is mixed with 1 mL of water, 1.75 mg equals 17.5 units; with 2 mL of water it equals 35 units; with 3 mL of water it equals 52.5 units. Always calculate from the label rather than copying someone else's syringe draw.
Can you take PT-141 daily?
No, the approved label does not support daily dosing. Vyleesi is limited to one dose per 24 hours and a maximum of eight doses per month. Frequent repeated use has been linked to hyperpigmentation and blood pressure changes, so daily use should only be considered under medical supervision.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.